Hedge Fund - Perceptive Advisors
Acelrx Pharmaceuticals Inc (ACRX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2017 - Q4 (2017-12-31) | $0 | 0% | 0 | $48.82 |
| 2 | 2017 - Q3 (2017-09-30) | $5,725,000 | 0.21% | 62,230.4 | $62.34 |
| 3 | 2017 - Q2 (2017-06-30) | $8,022,000 | 0.4% | 186,567.1 | $50.80 |
| 4 | 2017 - Q1 (2017-03-31) | $17,037,000 | 0.97% | 270,436.4 | $58.85 |
| 5 | 2016 - Q4 (2016-12-31) | $14,063,000 | 1% | 270,436.4 | $61.49 |
| 6 | 2016 - Q3 (2016-09-30) | $21,040,000 | 1.35% | 270,436.4 | $66.44 |
| 7 | 2016 - Q2 (2016-06-30) | $16,129,000 | 1.11% | 299,788 | $65.52 |
| 8 | 2016 - Q1 (2016-03-31) | $18,466,000 | 1.61% | 299,788 | $69.36 |
| 9 | 2015 - Q4 (2015-12-31) | $23,084,000 | 1.7% | 299,788 | $85.80 |
| 10 | 2015 - Q3 (2015-09-30) | $19,105,000 | 1.52% | 313,203 | $82.19 |
| 11 | 2015 - Q2 (2015-06-30) | $27,874,000 | 1.67% | 328,703 | $78.21 |
| 12 | 2015 - Q1 (2015-03-31) | $25,376,000 | 1.97% | 328,703 | $130.81 |
| 13 | 2014 - Q4 (2014-12-31) | $44,243,000 | 3.71% | 328,703 | $129.73 |
| 14 | 2014 - Q3 (2014-09-30) | $36,092,000 | 3.91% | 328,703 | $157.26 |
| 15 | 2014 - Q2 (2014-06-30) | $67,384,000 | 6.61% | 328,703 | $200.57 |
| 16 | 2014 - Q1 (2014-03-31) | $78,954,000 | 8.29% | 328,703 | $236.97 |
| 17 | 2013 - Q4 (2013-12-31) | $74,353,000 | 8.93% | 328,703 | $173.83 |
| 18 | 2013 - Q3 (2013-09-30) | $63,154,000 | 5.12% | 292,920 | $218.23 |
| 19 | 2013 - Q2 (2013-06-30) | $46,428,000 | 4.68% | 250,420 | $142.63 |
| 20 | 2013 - Q1 (2013-03-31) | $25,843,000 | 3.1% | 250,420 | $101.15 |
| 21 | 2012 - Q4 (2012-12-31) | $21,336,000 | 3.77% | 250,420 | $70.57 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:20.0000 on 2022-10-26